| 2025 | 2024 | 2023 | 2022 | 2021 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 511,5 k € | +44.5% | 354,0 k € | -24.7% | 470,1 k € | -1.9% | 479,0 k € | +19.9% | 399,4 k € | -24.2% | 526,7 k € | -1.8% | 536,5 k € | +3.9% | 516,4 k € | +31.9% | 391,6 k € | -5.5% | 414,3 k € | +32.7% | 312,1 k € | -4.1% | 325,5 k € | +6.8% | 304,9 k € | -10.1% | 339,3 k € | +8.6% | 312,4 k € | +45.0% | 215,5 k € | -6.9% | 231,4 k € | |
| EBITDA | 203,3 k € | +426.8% | -62,2 k € | -138.5% | 161,7 k € | +359.6% | 35,2 k € | +158.6% | -60,0 k € | -139.1% | 153,4 k € | -2.5% | 157,2 k € | +37.3% | 114,5 k € | +425.7% | 21,8 k € | -64.7% | 61,7 k € | +98.1% | 31,1 k € | +464.8% | 5,5 k € | -81.6% | 30,0 k € | -66.9% | 90,7 k € | -33.4% | 136,2 k € | +449.0% | 24,8 k € | -76.8% | 107,0 k € | |
| Operating profit | 167,7 k € | +281.7% | -92,3 k € | -170.4% | 131,1 k € | +557.2% | -28,7 k € | +67.8% | -89,1 k € | -168.9% | 129,3 k € | +11.2% | 116,2 k € | +38.8% | 83,7 k € | +799.9% | -12,0 k € | -135.2% | 34,0 k € | +459.8% | 6,1 k € | +127.2% | -22,3 k € | -2453.2% | 946,6 € | -98.4% | 58,6 k € | -46.0% | 108,5 k € | +6963.1% | 1,5 k € | -98.2% | 86,8 k € | |
| Profit/loss | 110,3 k € | +182.7% | -133,5 k € | -223.0% | 108,6 k € | +333.9% | -46,4 k € | +52.9% | -98,6 k € | -224.7% | 79,1 k € | +12.6% | 70,2 k € | +60.6% | 43,7 k € | +262.0% | -27,0 k € | -194.8% | 28,5 k € | +792.2% | 3,2 k € | +110.2% | -31,3 k € | -1094.0% | -2,6 k € | -106.5% | 40,2 k € | -47.0% | 75,8 k € | +614.8% | 10,6 k € | -82.2% | 59,5 k € | |
| Equity | 247,9 k € | +80.2% | 137,5 k € | -49.3% | 271,0 k € | +66.8% | 162,5 k € | -22.2% | 208,9 k € | -62.1% | 550,8 k € | +3.6% | 531,7 k € | +15.2% | 461,5 k € | +8.6% | 424,8 k € | +386.0% | 87,4 k € | -81.2% | 463,8 k € | +0.7% | 460,6 k € | -6.4% | 491,8 k € | -0.5% | 494,5 k € | +8.8% | 454,3 k € | +20.0% | 378,4 k € | +2.9% | 367,8 k € | |
| Total assets | 1,5 M € | -0.7% | 1,5 M € | +3.5% | 1,4 M € | +26.4% | 1,1 M € | -2.0% | 1,1 M € | +18.1% | 964,5 k € | +4.1% | 926,7 k € | +26.0% | 735,3 k € | -5.4% | 777,5 k € | -4.1% | 810,7 k € | +10.9% | 730,8 k € | +1.0% | 723,3 k € | +3.5% | 698,9 k € | -5.4% | 738,6 k € | +2.5% | 720,4 k € | +20.5% | 597,8 k € | -3.8% | 621,3 k € | |
| Cash | 9,9 k € | +1900.3% | 496,9 € | -99.2% | 59,7 k € | +674.2% | 7,7 k € | +45.8% | 5,3 k € | -96.4% | 148,2 k € | +18.4% | 125,1 k € | +2053.2% | 5,8 k € | -75.2% | 23,5 k € | -51.7% | 48,6 k € | +391.1% | 9,9 k € | -39.5% | 16,4 k € | -78.9% | 77,7 k € | -27.6% | 107,3 k € | +107.7% | 51,7 k € | -54.0% | 112,4 k € | -19.5% | 139,6 k € | |
| Debts | 1,2 M € | -7.3% | 1,3 M € | +13.3% | 1,1 M € | +23.2% | 913,6 k € | -1.4% | 926,4 k € | +123.9% | 413,7 k € | +4.8% | 394,8 k € | +44.6% | 273,1 k € | -22.5% | 352,4 k € | -51.3% | 723,1 k € | +171.1% | 266,8 k € | +1.6% | 262,5 k € | +26.9% | 206,8 k € | -15.2% | 243,8 k € | -8.3% | 265,9 k € | +21.3% | 219,1 k € | -13.5% | 253,2 k € | |
| Staff | 2,8 | 3,2 | 1,9 | 3,1 | 4,5 | 3,2 | 4,3 | 3,2 | 3,1 | 3,1 | 2,7 | 3 | 3,3 | 3,7 | 2,6 | 3,6 | 2,5 | |||||||||||||||||
Private limited company · Schoten · incorporated on 22/06/1995 · 2,8 ETP
Private limited company profitable and well capitalised. Cash position rising (+1900.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
D.E.N. MEDICAL is a Private limited company incorporated in 1995. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Schoten. It employs on average 2,8 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette